+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein



Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein



Korean Journal of Parasitology 49(4): 357-364



Various Leishmania species were engineered with green fluorescent protein (GFP) using episomal vectors that encoded an antibiotic resistance gene, such as aminoglycoside geneticin sulphate (G418). Most reports of GFP-Leishmania have used the flagellated extracellular promastigote, the stage of parasite detected in the midgut of the sandfly vector; fewer studies have been performed with amastigotes, the stage of parasite detected in mammals. In this study, comparisons were made regarding the efficiency for in vitro G418 selection of GFP-Leishmania amazonensis promastigotes and amastigotes and the use of in vivo G418 selection. The GFP-promastigotes retained episomal plasmid for a prolonged period and G418 treatment was necessary and efficient for in vitro selection. In contrast, GFP-amastigotes showed low retention of the episomal plasmid in the absence of G418 selection and low sensitivity to antibiotics in vitro. The use of protocols for G418 selection using infected BALB/c mice also indicated low sensitivity to antibiotics against amastigotes in cutaneous lesions.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056798900

Download citation: RISBibTeXText

PMID: 22355202


Related references

A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitology Research 89(4): 266-271, 2003

Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. Journal of Antimicrobial ChemoTherapy 64(2): 370-374, 2009

Monitoring BCG trafficking in vitro and in vivo using recombinant BCG expressing green fluorescent protein. Journal of Urology 157(4 Suppl. ): 309, 1997

Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Acta Tropica 122(1): 36-45, 2012

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. Journal of Infectious Diseases 196(Suppl. 2): S313-S322, 2007

An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein. Diagnostic Microbiology and Infectious Disease 75(3): 282-291, 2013

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis. Plos Neglected Tropical Diseases 6(11): E1927, 2012

In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. Journal of Virology 74(17): 7972-7979, 2000

Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. Journal of Neuroscience 23(12): 5004-5011, 2003

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite. Korean Journal of Parasitology 53(4): 385-394, 2015

In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells. Parasite Immunology 38(6): 365-376, 2016

In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis. Plos Neglected Tropical Diseases 6(5): E1626, 2012

Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite. Antimicrobial Agents and ChemoTherapy 59(4): 1910-1918, 2015

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis. Memorias do Instituto Oswaldo Cruz 103(4): 358-362, 2008

In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice. Journal of Microbiological Methods 130: 189-195, 2016